Myconanotechnology in veterinary sector: Status quo and future perspectives

Meeting Contemporary Challenges: Development of Nanomaterials for Veterinary Medicine

In recent decades, nanotechnology has been rapidly advancing in various fields of human activity, including veterinary medicine. The review presents up-to-date information on recent advancements in nanotechnology in the field and an overview of the types of nanoparticles used in veterinary medicine and animal husbandry, their characteristics, and their areas of application. Currently, a wide range of nanomaterials has been implemented into veterinary practice, including pharmaceuticals, diagnostic devices, feed additives, and vaccines. The application of nanoformulations gave rise to innovative strategies in the treatment of animal diseases. For example, antibiotics delivered on nanoplatforms demonstrated higher efficacy and lower toxicity and dosage requirements when compared to conventional pharmaceuticals, providing a possibility to solve antibiotic resistance issues. Nanoparticle-based drugs showed promising results in the treatment of animal parasitoses and neoplastic diseases. However, the latter area is currently more developed in human medicine. Owing to the size compatibility, nanomaterials have been applied as gene delivery vectors in veterinary gene therapy. Veterinary medicine is at the forefront of the development of innovative nanovaccines inducing both humoral and cellular immune responses. The paper provides a brief overview of current topics in nanomaterial safety, potential risks associated with the use of nanomaterials, and relevant regulatory aspects.

Mycosynthesis of Metal-Containing Nanoparticles-Fungal Metal Resistance and Mechanisms of Synthesis

In the 21st century, nanomaterials play an increasingly important role in our lives with applications in many sectors, including agriculture, biomedicine, and biosensors. Over the last two decades, extensive research has been conducted to find ways to synthesise nanoparticles (NPs) via mediation with fungi or fungal extracts. Mycosynthesis can potentially be an energy-efficient, highly adjustable, environmentally benign alternative to conventional physico-chemical procedures. This review investigates the role of metal toxicity in fungi on cell growth and biochemical levels, and how their strategies of resistance, i.e., metal chelation, biomineral formation, biosorption, bioaccumulation, compartmentalisation, and efflux of metals from cells, contribute to the synthesis of metal-containing NPs used in different applications, e.g., biomedical, antimicrobial, catalytic, biosensing, and precision agriculture. The role of different synthesis conditions, including that of fungal biomolecules serving as nucleation centres or templates for NP synthesis, reducing agents, or capping agents in the synthesis process, is also discussed. The authors believe that future studies need to focus on the mechanism of NP synthesis, as well as on the influence of such conditions as pH, temperature, biomass, the concentration of the precursors, and volume of the fungal extracts on the efficiency of the mycosynthesis of NPs.

Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa

Ganoderma lucidum is a well-known medicinal mushroom that has been used for the prevention and treatment of different ailments to enhance longevity and health specifically in China, Japan, and Korea. It was known as “God’s herb” in ancient China as it was believed to prolong life, enhance the youthful spirit and sustain/preserve vitality. G. lucidum is seldom collected from nature and is substantially cultivated on wood logs and sawdust in plastic bags or bottles to meet the international market demand. Both in vitro and in vivo studies on the copious metabolic activities of G. lucidum have been carried out. Varied groups of chemical compounds including triterpenoids, polysaccharides, proteins, amino acids, nucleosides, alkaloids, steroids, lactones, lectins, fatty acids, and enzymes with potent pharmacological activities have been isolated from the mycelia and fruiting bodies of G. lucidum. Several researchers have reported the abundance and diversification of its biological actions triggered by these chemical compounds. Triterpenoids and polysaccharides of G. lucidum have been reported to possess cytotoxic, hepatoprotective, antihypertensive, hypocholesterolemic, antihistaminic effects, antioxidant, antimicrobial, anti-inflammatory, hypoglycemic antiallergic, neuroprotective, antitumor, immunomodulatory and antiangiogenic activities. Various formulations have been developed, patented, and utilized as nutraceuticals, cosmeceuticals, and pharmaceuticals from G. lucidum extracts and active compounds. Thus, this review presents current updates on emerging infectious diseases and highlights the scope, dynamics, and advances in infectious disease management with a particular focus on Ganoderma lucidum, an unutilized natural medicine as a promising future solution to emerging diseases in Africa. However, details such as the chemical compound and mode of action of each bioactive against different emerging diseases were not discussed in this study.

Biosynthesis and characterization of extracellular metabolites-based nanoparticles to control the whitefly

The Beauveria spp. were isolated from soil and insect cadavers and confirmed as Beauveria bassiana by molecular identification using a specific primer. The bioefficacy of 14 B. bassiana against whiteflies indicated the highest percent mortality in JAU2, followed by JAU1. The LC₅₀ and LC₉₀ values were found to be 0.043 × 10⁵ and 0.05 × 10¹⁴ conidia.ml^-1, respectively, in JAU2. Extracellular metabolites of B.bassiana are derived and used for the green synthesis of silver nanoparticles (AgNPs). The synthesized green AgNPs were characterized for size (24.8 nm), shape (scanning electron microscopy), stability (200 mV zeta), and purity (energy-dispersive X-ray spectroscopy, 3 keV). A total of 63 extracellular metabolites were identified using LC-MS/QTOF in potent JAU2 with recognition of alcohols, phenols, carboxylic acids, amines, alkynes, and amides as functional groups. The functional groups of green AgNPs were also confirmed in Fourier transforms infrared spectroscopy (FTIR) with the specific spectra in the electromagnetic spectrum. The relationship between identified metabolites of antagonist and the FTIR spectrum of the functional group indicated the involvement of extracellular novel compounds, viz., homoisocitrate, aconitine, phodexin A, capillone, solanocapsine, and anethole in the synthesis of green AgNPs. The efficacy of green AgNPs on whiteflies suggested that corrected percent mortality was observed at 60 µg Ag.ml^-1 at 120 h, which corresponds to the LC₅₀ value (66.42 µg Ag.ml^-1). Results were interpreted to show that green AgNPs synthesized from extracellular metabolites of B.bassiana JAU2 gave better insecticidal activity at LC₅₀ as compared to live antagonist JAU2.

Fungi as veritable tool in current advances in nanobiotechnology

Fungi have great prospects for synthesis, applications and developing new products in nanotechnology. In recent times, fungi use in nanotechnology is gaining more attention because of the ecological friendly state of their metabolite-mediated nanoparticles, their safety, amenability and applications in diverse fields. The diversity of the metabolites such as enzymes, polysaccharide, polypeptide, protein and other macro-molecules has made fungi a veritable tool for nanoparticles synthesis. Mechanism of fungal nano-biosynthesis from the molecular perspective has been extensively studied through various investigations on its green synthesized metal nanoparticles. Fungal nanobiotechnology has been applied in agricultural, medical and industrial sectors for goods and services improvement and delivery to mankind. Agriculturally, it has found applications in plant disease management and production of environmentally friendly, non-toxic insecticides, fungicides to enhance agricultural production in general. Medically, diagnosis and treatment of diseases, especially of microbial origin have been improved with fungal nanoparticles through more efficient drug delivery systems with great benefits to pharmaceutical industries. This review therefore explored fungal nanobiotechnology; mechanism of synthesis, characterization and potential applications in various fields of human endeavours for goods and services delivery.